Journal
ANALYST
Volume 141, Issue 2, Pages 382-392Publisher
ROYAL SOC CHEMISTRY
DOI: 10.1039/c5an01762a
Keywords
-
Categories
Funding
- Fusion Technology Development Program through the Small and Medium Business Administration (SMBA, Korea) [S2174432]
- center for BioNano Health-Guard - Ministry of Science, ICT & Future Planning of Korea as a Global Frontier Project [H-GUARD 2013M3A6B2078959]
- National Research Foundation of Korea (NRF) grant - Korea government (MSIP) [2015R1A2A2A04006450]
Ask authors/readers for more resources
Much research has been performed over the past several decades in an attempt to conquer cancer. Tissue biopsy is the conventional method for gathering biological materials to analyze cancer and has contributed greatly to the understanding of cancer. However, this method is limited because it is time-consuming (requires tissue sectioning, staining, and pathological analysis), costly, provides scarce starting materials for multiple tests, and is painful. A liquid biopsy, which analyzes cancer-derived materials from various body fluids using a minimally invasive procedure, is more practical for real-time monitoring of disease progression than tissue biopsy. Biomarkers analyzable through liquid biopsy include circulating tumor cells (CTCs), exosomes, circulating cell-free DNA (cfDNA), miRNA, and proteins. Research on CTCs has been actively conducted because CTCs provide information on the whole cell, unlike the other biomarkers mentioned above. However, owing to the rarity and heterogeneity of CTCs, CTC research faces many critical concerns. Although exosomes and cfDNA have some technical challenges, they are being highlighted as new target materials. That is because they also have genetic information on cancers. Even though the number of exosomes and cfDNA from early stage cancer patients are similar to healthy individuals, they are present in high concentrations after metastasis. In this article, we review several technologies for material analyses of cancer, discuss the critical concerns based on hands-on experience, and describe future directions for cancer screening, detection, and diagnostics.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available